Daiichi Sankyo has hired Shun Asami, previously senior investment director and San Francisco division head at Eisai Innovation.
Shun Asami has departed from Eisai Innovation, the corporate venturing arm of Eisai, and joined another Japanese pharmaceutical company Daiichi Sankyo as a manager.
Asami held positions as senior investment director and San Francisco division head for three years from 2019.
Formed in 2019, Eisai Innovation focuses on healthcare investment opportunities, concentrating on neurology and oncology as well as diagnostics technologies.
Eisai Innovation‘s US-based portfolio companies…
